At JC Analytical we routinely test a range of samples including Active Pharmaceutical Ingredients (APIs), bulk drugs, intermediates, excipients, finished products, cosmetics and products for veterinary use. Testing methods used are either from the current pharmacopoeias (EP / USP / BP / JP), supplied by our clients to their own specification or may be developed and validated ‘in house’ by our own development section. We offer a wide range of analytical testing techniques to suit your individual requirements undertaken to cGMP quality standards.
MHRA accredited services utilising current pharmacopoeias (EU/USP/BP/JP)
- European Pharmacopoeia (EP)
- United States Pharmacopoeia (USP)
- British Pharmacopoeia (BP)
- Japanese Pharmacopoeia (JP)
Supporting our clients through the drug lifecycle:
| Early Phase Development | Evaluation, optimisation and scale-up | Registration and marketed product |
|---|---|---|
| Method development and validation | Stability Testing | Raw material analysis |
| Method optimisation and validation | Method evaluation and optimisation | Stability Storage and Testing |
| Accelerated Storage Condition Programs | Method validation | Dissolution |
| Impurity analysis | Method transfer | Batch release |
| Release testing |
